ConductScience.org, home

Paper21477288

Histone modification enhances the effectiveness of IL-13 receptor targeted immunotoxin in murine models of human pancreatic cancer.

Fujisawa T and 2 others. J Transl Med, 2011. Cited by 27 papers, by iCite.

Cite this record

ConductScience Library. Histone modification enhances the effectiveness of IL-13 receptor targeted immunotoxin in murine models of human pancreatic cancer. Papers, record 21477288. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21477288

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Histone modification enhances the effectiveness of IL-13 receptor targeted immunotoxin in murine models of human pancreatic cancer.
PubMed
Journal
J Transl Med
PubMed
Year
2011
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
0.63
iCite
Revised in PubMed
2021-10-20
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fujisawa TToshio
2Joshi BHBharat H
3Puri RKRaj K

Source PubMed

Download CSV of authors

Topics23

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HistonesMajor topic
ImmunotoxinsMajor topic
Pancreatic NeoplasmsMajor topic
Protein Processing, Post-TranslationalMajor topic
Receptors, Interleukin-13Major topic
Acetylation
Animals
Base Sequence
Cell Line, Tumor
DNA Methylation
DNA Mutational Analysis
DNA, Complementary
Disease Models, Animal
Gene Expression Regulation, Neoplastic
Histone Deacetylase Inhibitors
Humans
Interleukin-13
Matrix Metalloproteinases
Mice
Promoter Regions, Genetic
Transcription Factor AP-1
Up-Regulation
Xenograft Model Antitumor Assays

Source PubMed

Download CSV of topics

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116264908Drug insight: Histone deacetylase inhibitors--development of the new targeted anticancer agent suberoylanilide hydroxamic acid.Nat Clin Pract Oncol2005https://conductscience.org/library/papers/16264908PubMed
28639793Targeting of interleukin-13 receptor on human renal cell carcinoma cells by a recombinant chimeric protein composed of interleukin-13 and a truncated form of Pseudomonas exotoxin A (PE38QQR).Blood1996https://conductscience.org/library/papers/8639793PubMed
315164071Epigenetics in human disease and prospects for epigenetic therapy.Nature2004https://conductscience.org/library/papers/15164071PubMed
411882541Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics.EMBO Rep2002https://conductscience.org/library/papers/11882541PubMed
519833297Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies.Lancet Neurol2009https://conductscience.org/library/papers/19833297PubMed
69815666Receptor for interleukin 13 on AIDS-associated Kaposi's sarcoma cells serves as a new target for a potent Pseudomonas exotoxin-based chimeric toxin protein.Clin Cancer Res1997https://conductscience.org/library/papers/9815666PubMed
77622490A novel chimeric protein composed of interleukin 13 and Pseudomonas exotoxin is highly cytotoxic to human carcinoma cells expressing receptors for interleukin 13 and interleukin 4.J Biol Chem1995https://conductscience.org/library/papers/7622490PubMed
819010904Human adrenomedullin up-regulates interleukin-13 receptor alpha2 chain in prostate cancer in vitro and in vivo: a novel approach to sensitize prostate cancer to anticancer therapy.Cancer Res2008https://conductscience.org/library/papers/19010904PubMed
99815919Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and pseudomonas exotoxin.Clin Cancer Res1995https://conductscience.org/library/papers/9815919PubMed
1012816724Molecular cloning and identification of the human interleukin 13 alpha 2 receptor (IL-13Ra2) promoter.Neuro Oncol2003https://conductscience.org/library/papers/12816724PubMed
1116618770Characterization of a novel human tumor antigen interleukin-13 receptor alpha2 chain.Cancer Res2006https://conductscience.org/library/papers/16618770PubMed
1215604287Specific recognition and killing of glioblastoma multiforme by interleukin 13-zetakine redirected cytolytic T cells.Cancer Res2004https://conductscience.org/library/papers/15604287PubMed
1312445278Cancer/testis antigens: an expanding family of targets for cancer immunotherapy.Immunol Rev2002https://conductscience.org/library/papers/12445278PubMed
1415642470Optimization of expression and purification of two biologically active chimeric fusion proteins that consist of human interleukin-13 and Pseudomonas exotoxin in Escherichia coli.Protein Expr Purif2005https://conductscience.org/library/papers/15642470PubMed
1519887609A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis.Cancer Res2009https://conductscience.org/library/papers/19887609PubMed
1611696577Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia.J Clin Invest2001https://conductscience.org/library/papers/11696577PubMed
1712060640
Heterogeneity in interleukin-13 receptor expression and subunit structure in squamous cell carcinoma of head and neck: differential sensitivity to chimeric fusion proteins comprised of interleukin-13 and a mutated form of Pseudomonas exotoxin.
Clin Cancer Res2002https://conductscience.org/library/papers/12060640PubMed
1819861533Enhanced antitumor activity induced by adoptive T-cell transfer and adjunctive use of the histone deacetylase inhibitor LAQ824.Cancer Res2009https://conductscience.org/library/papers/19861533PubMed
1918665158Interleukin-13 displaying retargeted oncolytic measles virus strains have significant activity against gliomas with improved specificity.Mol Ther2008https://conductscience.org/library/papers/18665158PubMed
2020068108Interleukin 13 mediates signal transduction through interleukin 13 receptor alpha2 in pancreatic ductal adenocarcinoma: role of IL-13 Pseudomonas exotoxin in pancreatic cancer therapy.Clin Cancer Res2010https://conductscience.org/library/papers/20068108PubMed

See all 34 referencesDownload CSV of references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
40542937Advances in the Optimization of CAR-T-Cell-Based Therapeutic Approaches to Enhance Antitumor Efficacy in Glioblastoma Treatment.Oncol Ther2025https://conductscience.org/library/papers/40542937PubMed
38685487Identification and characterisation of novel CAR-T cells to target IL13Rα2 positive human glioma in vitro and in vivo.Clin Transl Med2024https://conductscience.org/library/papers/38685487PubMed
38573683Applications and Opportunities for Immune Cell CAR Engineering in Comparative Oncology.Clin Cancer Res2024https://conductscience.org/library/papers/38573683PubMed
37345109Targeting and Sensitization of Breast Cancer Cells to Killing with a Novel Interleukin-13 Receptor α2-Specific Hybrid Cytolytic Peptide.Cancers (Basel)2023https://conductscience.org/library/papers/37345109PubMed
36830725Targeting of the Interleukin-13 Receptor (IL-13R)α2 Expressing Prostate Cancer by a Novel Hybrid Lytic Peptide.Biomolecules2023https://conductscience.org/library/papers/36830725PubMed
35464460Recent Advances in IL-13Rα2-Directed Cancer Immunotherapy.Front Immunol2022https://conductscience.org/library/papers/35464460PubMed
34201539IL-13Rα2 Is a Biomarker of Diagnosis and Therapeutic Response in Human Pancreatic Cancer.Diagnostics (Basel)2021https://conductscience.org/library/papers/34201539PubMed
34198989Epigenetics of Most Aggressive Solid Tumors: Pathways, Targets and Treatments.Cancers (Basel)2021https://conductscience.org/library/papers/34198989PubMed
33804263Involvement of IL-4, IL-13 and Their Receptors in Pancreatic Cancer.Int J Mol Sci2021https://conductscience.org/library/papers/33804263PubMed
32443847A Novel Role of Interleukin 13 Receptor alpha2 in Perineural Invasion and its Association with Poor Prognosis of Patients with Pancreatic Ductal Adenocarcinoma.Cancers (Basel)2020https://conductscience.org/library/papers/32443847PubMed
31607839Five Novel Genes Related to the Pathogenesis and Progression of Pancreatic Neuroendocrine Tumors by Bioinformatics Analysis With RT-qPCR Verification.Front Neurosci2019https://conductscience.org/library/papers/31607839PubMed
27623944IL-13 receptor α2 stimulates human glioma cell growth and metastasis through the Src/PI3K/Akt/mTOR signaling pathway.Tumour Biol2016https://conductscience.org/library/papers/27623944PubMed
25799412SCF, regulated by HIF-1α, promotes pancreatic ductal adenocarcinoma cell progression.PLoS One2015https://conductscience.org/library/papers/25799412PubMed
25346520Engineering toxin-resistant therapeutic stem cells to treat brain tumors.Stem Cells2015https://conductscience.org/library/papers/25346520PubMed
23533247TOP2A is overexpressed and is a therapeutic target for adrenocortical carcinoma.Endocr Relat Cancer2013https://conductscience.org/library/papers/23533247PubMed
22981627The future of human DNA vaccines.J Biotechnol2012https://conductscience.org/library/papers/22981627PubMed
22770803Targeting the MAGE A3 antigen in pancreatic cancer.Surgery2012https://conductscience.org/library/papers/22770803PubMed

Download CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
HDAC99734PubTator's text mininghttps://conductscience.org/library/genes/9734NCBI Gene
IL133596PubTator's text mininghttps://conductscience.org/library/genes/3596NCBI Gene
IL13RA23598PubTator's text mininghttps://conductscience.org/library/genes/3598NCBI Gene
JUN3725PubTator's text mininghttps://conductscience.org/library/genes/3725NCBI Gene
JUNB3726PubTator's text mininghttps://conductscience.org/library/genes/3726NCBI Gene
POTEF728378PubTator's text mininghttps://conductscience.org/library/genes/728378NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21477288

GET https://conductscience.org/api/papers/v1/21477288/references?page=2